SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009286
Filing Date
2019-05-09
Accepted
2019-05-09 16:02:58
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20190331_10q.htm 10-Q 991072
2 EXHIBIT 31.1 ex_143097.htm EX-31.1 11957
3 EXHIBIT 31.2 ex_143098.htm EX-31.2 12001
4 EXHIBIT 32 ex_143099.htm EX-32 7142
  Complete submission text file 0001437749-19-009286.txt   5617790

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pgnx-20190331.xml EX-101.INS 1321768
6 XBRL TAXONOMY EXTENSION SCHEMA pgnx-20190331.xsd EX-101.SCH 59670
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pgnx-20190331_cal.xml EX-101.CAL 45726
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgnx-20190331_def.xml EX-101.DEF 347943
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgnx-20190331_lab.xml EX-101.LAB 315840
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgnx-20190331_pre.xml EX-101.PRE 383908
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 19810408
SIC: 2834 Pharmaceutical Preparations